Fidelity Worldwide Investment has cut the price of its index tracker range, putting pressure on rivals who now charge more than double the price on some products.
Hargreaves Lansdown has secured what it says is the cheapest share class in the market for Neil Woodford's new fund, selling the investment star's fund for 60bps.
The official UK interest rate could settle at an average of 3% in a few years, the outgoing Deputy Governor of the Bank of England has predicted.
PIMCO is continuing its expansion into equities with a number of new funds.
Britain's two state-backed banks have retreated from lending to the London property market since the financial crisis, in a sign of caution amid fears of an inflating housing bubble.
A row has broken out over the cost of setting up all of the public bodies needed in an independent Scotland.
The 'considerable reversal' in the fortunes of mid- and small-cap stocks seen since the start of March is likely to continue as large caps come back into favour, according to Jupiter's John Chatfeild-Roberts.
US pharmaceutical giant Pfizer has abandoned its plans to buy AstraZeneca following an unsuccessful pursuit of its UK rival.
Newly-launched boutique Sanditon Asset Management, formed by ex-Cazenove managers Tim Russell and Chris Rice, is poised to launch an investment trust within the next four weeks.
Lloyds Banking Group has announced plans to float a 25% stake in its TSB business next month in a bid to meet European rules on state aid for banks.